REG - BioPharma Credit PLC - Total Voting Rights

Biopharma CreditAnnouncement

Thu 12:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250501:nRSA0929Ha&default-theme=true

RNS Number : 0929H  BioPharma Credit PLC  01 May 2025

BioPharma Credit plc

(the "Company")

TOTAL VOTING RIGHTS

 

In conformity with the Disclosure Guidance and Transparency Rules, the Company
notifies the market that the issued share capital and voting rights of the
Company, as at 30 April 2025, were as follows:

 

 Class of share         Total number of shares in circulation  Number of voting rights attached to each share  Total number of voting rights of shares in circulation  Number of shares held in treasury  Total number of shares in issue
 Ordinary $0.01 shares  1,129,327,778                          1                                               1,129,327,778                                           244,604,289                        1,373,932,067

 

The above total voting rights figure may be used by shareholders as the
denominator for the calculations by which they will determine whether they are
required to notify their interest in BioPharma Credit PLC under the FCA's
Disclosure Guidance and Transparency Rules.

 

1 May 2025

 

 

LEI: 213800AV55PYXAS7SY24

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVREAFSFEDSSEFA